ArticleNeuropsychiatric disease and treatment2025
Associations Between Anorexia Nervosa Severity, Liver Dysfunction, and Cobalamin Serum Concentration.
Article in Neuropsychiatric disease and treatment, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
9 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Anorexia nervosa (AN) is a severe psychiatric disorder characterized by extreme malnutrition, leading to multiple organ dysfunctions, including liver impairment. While AST and ALT are standard markers for liver dysfunction, recent reports suggest that elevated cobalamin (vitamin B12) levels are frequently observed in AN patients. However, the association between cobalamin levels and liver dysfunction remains unclear. This study aims to investigate the relationship between cobalamin levels, liver enzyme abnormalities, and body mass index (BMI) in AN patients. Methods: This retrospective observational study included patients diagnosed with AN who visited the outpatient department or were hospitalized at Yokohama City University Medical Center between April 2012 and March 2021. Patients with alcohol use disorder, cancer, or vitamin supplementation were excluded. AST, ALT, and cobalamin levels were measured during routine blood tests, and BMI was calculated based on clinical records. Results: BMI was significantly negatively correlated with AST (r = -0.4703, p < 0.0001) and ALT (r = -0.3743, p < 0.0001). Patients with cobalamin levels >4000 pg/mL exhibited significantly lower BMI compared to those with lower cobalamin levels. Additionally, higher cobalamin levels were associated with increased AST and ALT levels. Conclusion: Elevated cobalamin levels, alongside AST and ALT, may serve as a possible supportive indicator of liver dysfunction and the severity of malnutrition in AN patients. Further research is needed to clarify the underlying mechanisms and clinical implications for nutritional assessment and liver dysfunction evaluation.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.